SPAGO — Spago Nanomedical AB (publ) Share News
0.000.00%
Last trade - 00:00- SEK88.14m
- SEK62.21m
- SEK0.44m
Brief: Spago Nanomedical Gets Patent Approved In Japan
Brief: Spago Nanomedical Jan-March Net Loss Widens To SEK 5.1 Mln
Brief: Spago Nanomedical Pauses Recruitment For Clinical Study In Uppsala
Brief: Spago Nanomedical Decides On Rights Issue Of SEK 47 Million
Brief: Spagopix Says Phase I Study To Next Dose Level And Expansion To Additional Site
Brief: Spago Nanomedical Appoints Lead Compound In The Tumorad-Project
Brief: Spago Nanomedical Q2 Operating Loss Widens To SEK 4.5 Mln
Brief: Spago Nanomedical Gets European Patent
Brief: Spago Nanomedical Gets SEK 6.5 Mln Through Exercise Of Warrants
Brief: Spago Nanomedical Gets About SEK 30.2 Mln Via Exercise Of Warrants
Brief: Spago Nanomedical Proposes Dr. Eugen Steiner As New Chairman
Brief: Spago Nanomedical AB (Publ) Intends To Change Market Place To Nasdaq First North
Brief: Spago Nanomedical: Tumorad Patent Granted In Europe
Brief: Spago Nanomedical AB (Publ) Carries Out Directed Issue Of Sek 18.2 Million
Brief: Spago Nanomedical: US Patent Granted For Tumorad
Brief: Spago Nanomedical Signs Agreement For Conduct Of Clinical Study With SpagoPix
Brief: Spago Nanomedical: SpagoPix Shows Good Safety In Regulatory Preclinical Studies
Brief: Spago Nanomedical Receives Grant From Vinnova For The Development Of Spagopix
Brief: Spago Nanomedical Jan-March Net Loss Widens To SEK 2.5 Million